Rockwell Medical, Inc. (RMTI) earnings
RMTI earnings moved a median of 0.00% by the close. Quarterly and annual RMTI reports and results, each read against the price at its own news timestamp. Back to the RMTI overview →
31 measured RMTI earnings events.
Where these RMTI earnings landedvs 31 measured RMTI earnings reactions
| Middle 50% of RMTI earnings reactions | -5.56% to +2.16% |
|---|---|
| Median reaction (to close) | 0.00% |
| Measured reactions | 31 |
Point-in-time · zero look-ahead
Half of the 31 RMTI earnings events with a measured close landed between -5.56% and +2.16%; 48% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Rockwell Medical to Release Third Quarter 2026 Results on Thursday, November 12, 2026 | Press release | +4.30% | +3.91% | |
| Form 10-Q ROCKWELL MEDICAL, INC. For: Jun 30 | SEC filing · Form 10-Q | -2.60% | +1.62% | |
| Rockwell Medical Announces Second Quarter 2026 Results | Press release | -2.60% | +1.62% | |
| Rockwell Medical to Release Second Quarter 2026 Results on Thursday, August 13, 2026 | Press release | -0.18% | +2.14% | |
| Form 10-Q ROCKWELL MEDICAL, INC. For: Mar 31 | SEC filing · Form 10-Q | -5.34% | -2.08% | |
| Rockwell Medical Announces First Quarter 2026 Results and Additional 2026 Guidance with Focus on Profitability | Press release | -5.34% | -2.08% | |
| Rockwell Medical to Release First Quarter 2026 Results on Thursday, May 7, 2026 | Press release | +2.21% | -0.98% | |
| Form 10-K ROCKWELL MEDICAL, INC. For: Dec 31 | SEC filing · Form 10-K | -1.09% | +4.68% | |
| Form 10-Q ROCKWELL MEDICAL, INC. For: Sep 30 | SEC filing · Form 10-Q | +2.72% | +0.62% | |
| Rockwell Medical Announces Third Quarter 2025 Results | Press release | +2.72% | +0.62% | |
| Rockwell Medical to Release Third Quarter 2025 Results on Wednesday, November 12, 2025 | Press release | +0.42% | +0.00% | |
| Form 10-Q ROCKWELL MEDICAL, INC. For: Jun 30 | SEC filing · Form 10-Q | +3.13% | +9.38% | |
| Rockwell Medical Announces Second Quarter 2025 Results | Press release | +3.13% | +9.38% | |
| Rockwell Medical to Release Second Quarter 2025 Results on Thursday, August 14, 2025 | Press release | -1.75% | -0.91% | |
| Form 10-Q ROCKWELL MEDICAL, INC. For: Mar 31 | SEC filing · Form 10-Q | -3.02% | -19.38% | |
| Rockwell Medical Announces First Quarter 2025 Results | Press release | -3.02% | -19.38% | |
| Rockwell Medical to Release First Quarter 2025 Results on Monday, May 12, 2025 | Press release | -0.62% | -4.13% | |
| Form 10-K ROCKWELL MEDICAL, INC. For: Dec 31 | SEC filing · Form 10-K | +3.65% | +2.19% | |
| Form 10-Q ROCKWELL MEDICAL, INC. For: Sep 30 | SEC filing · Form 10-Q | -9.43% | -19.14% | |
| Rockwell Medical Reports Third Quarter 2024 Earnings, Generates Profitability on a Cash Flow and Adjusted EBITDA Basis for the Second Consecutive Quarter | Press release | -9.43% | -19.14% | |
| Rockwell Medical Announces Date Change for Third Quarter 2024 Earnings Conference Call and Webcast | Press release | -2.52% | +0.68% | |
| Rockwell Medical to Release Third Quarter 2024 Results on Monday, November 11, 2024 | Press release | +1.44% | +0.29% | |
| Form 10-Q ROCKWELL MEDICAL, INC. For: Jun 30 | SEC filing · Form 10-Q | +2.91% | +3.88% | |
| Rockwell Medical to Release Second Quarter 2024 Results on Thursday, August 8, 2024 | Press release | +0.00% | +4.73% | |
| Form 10-Q ROCKWELL MEDICAL, INC. For: Mar 31 | SEC filing · Form 10-Q | +0.59% | -5.56% | |
| Rockwell Medical Announces First Quarter 2024 Results, Raises 2024 Guidance | Press release | +0.59% | -5.56% | |
| Rockwell Medical to Release First Quarter 2024 Results on Tuesday, May 14, 2024 | Press release | +0.00% | -1.97% | |
| Form 10-K ROCKWELL MEDICAL, INC. For: Dec 31 | SEC filing · Form 10-K | +3.45% | +17.93% | |
| Rockwell Medical Achieves Profitability on an Adjusted EBITDA Basis in the Fourth Quarter 2023 and Record Net Sales, Gross Profit and Gross Margin for the Full-Year 2023 | Press release | -8.00% | -13.14% | |
| Form 10-Q ROCKWELL MEDICAL, INC. For: Sep 30 | SEC filing · Form 10-Q | -3.69% | -9.68% | |
| Rockwell Medical Announces Third Quarter 2023 Results | Press release | -3.69% | -9.68% |
Keep exploring
More RMTI: analyst actions → · SEC filings → · RMTI overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Assembly Biosciences, Inc. (ASMB) | 236 | -0.01% | 41% |
| Fortress Biotech, Inc. (FBIO) | 235 | -0.68% | 37% |
| Equillium, Inc. (EQ) | 234 | 0.00% | 51% |
| Eton Pharmaceuticals, Inc. (ETON) | 234 | -0.34% | 40% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.